Annals of Oncology

In this issue:

In this issue
Ann Oncol 5: 667.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 5: 667.
[PDF] [Request Permissions]

News:

Cancer services in England and Wales: A restructuration is needed
Ann Oncol 5: 668-669.
[PDF] [Request Permissions]

Steven Dickman

"We're not just readouts of our genes": Harvard Professor criticizes Human Genome Project
Ann Oncol 5: 669-670.
[PDF] [Request Permissions]

Tragic worsening of health indicators in the former Soviet Union
Ann Oncol 5: 670-671.
[PDF] [Request Permissions]

Threats to clinical cancer research: Will a new methodology help?
Ann Oncol 5: 671-672.
[PDF] [Request Permissions]

Lisbon: Already a success
Ann Oncol 5: 672.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 5: 672-673.
[PDF] [Request Permissions]

Editorials:

M. H. N. Tattersall

Dose intensity in breast cancer chemotherapy – the way ahead?
Ann Oncol 5: 674-675.
[PDF] [Request Permissions]

Do we know the treatment of choice for hairy cell leukemia?
Ann Oncol 5: 676-677.
[PDF] [Request Permissions]

Book reviews:

Richard H. Greiner

Book review
Ann Oncol 5: 675.
[PDF] [Request Permissions]

R. Stahel

Book review
Ann Oncol 5: 678.
[PDF] [Request Permissions]

M. Tada and N. de Tribolet

Book review
Ann Oncol 5: 702.
[PDF] [Request Permissions]

Emanuele Zucca

Book review
Ann Oncol 5: 770.
[PDF] [Request Permissions]

Review:

A. Kragh Larsen

Involvement of DNA topoisomerases and DNA topoisomerase inhibitors in the induction of leukemia cell differentiation
Ann Oncol 5: 679-688.
[PDF] [Request Permissions]

Commentary:

R. P. Gale, T. A. Waldmann, J. O. Armitage, and F. Cavalli

Recent progress in B- and T-cell lymphomas
Ann Oncol 5: 689-696.
[PDF] [Request Permissions]

Introduction:

Maurizio D'lncalci

Immunoconjugates: The magic bullet revisited or future tumour-targeting therapy?
Ann Oncol 5: 697.
[PDF] [Request Permissions]

Arena:

S. Canevari, M. Colombatti, and M. I. Colnaghi

Immunoconjugates: Lessons from animal models
Ann Oncol 5: 698-701.
[Abstract] [PDF] [Request Permissions]

A. M. Casazza, P. A. Trail, and K. E. Hellström

Drug immunotargeting for carcinomas: A reality at last?
Ann Oncol 5: 703-708.
[PDF] [Request Permissions]

Original articles:

J. A. O'Shaughnessy, A. M. Denicoff, D. J. Venzon, D. Danforth, L. J. Pierce, J. N. Frame, A. Bastian, B. Ghosh, B. Goldspiel, L. Miller, F. A. Dorr, P. Keegan, N. Ben-Bamch, H. Mrose, M. Noone, and K. H. Cowan

A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients
Ann Oncol 5: 709-716.
[Abstract] [PDF] [Request Permissions]

M. Castiglione-Gertsch, C. Johnsen, A. Goldhirsch, R. D. Gelber, C. M. Rudenstam, J. Collins, J. Lindtner, A. Hacking, H. Cortes-Funes, J. Forbes, J. Simpson, M.H. N. Tattersall, K. Brunner, F. Cavalli, H.J. Senn, and International Breast CancerStudy Group (IBCSG), Bern (Switzerland)

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up
Ann Oncol 5: 717-724.
[Abstract] [PDF] [Request Permissions]

M. Federico, A. Frassoldati, T. Lamparelli, R. Foà, M. Brugiatelli, L. Annino, L. Baldini, G. Capnist, T. Chisesi, P. F. di Celle, R. Invernizzi, F. Lauria, M. Truini, L. Resegotti, V. Silingardi, E. E. Damasio, and for the ICGHCL

Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL
Ann Oncol 5: 725-731.
[Abstract] [PDF] [Request Permissions]

W. J. M. Jansen, H. M. Pinedo, C. M. Kuiper, C. Lincke, U. Bamberger, A. Heckel, and E. Boven

Biochemical modulation of ‘classical’ multidrug resistance by BIBW22BS, a potent derivative of dipyridamole
Ann Oncol 5: 733-739.
[Abstract] [PDF] [Request Permissions]

M. Lopez, S. Carpano, R. Cavaliere, L. Di Lauro, F. Ameglio, G. Vitelli, A. M. Frasca, P. Vici, F. Pignatti, M. Rosselli, G. Rasi, and E. Garaci

Biochemotherapy with thymosin l, interleukin-2 and dacarbazine in patients with metastatic melanoma: Clinical and immunological effects
Ann Oncol 5: 741-746.
[Abstract] [PDF] [Request Permissions]

F. Levi, C. La Vecchia, L. Randimbison, and V.-C. Te

Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991
Ann Oncol 5: 747-752.
[Abstract] [PDF] [Request Permissions]

Clinical case:

M. E. R. O'Brien, T. Perren, S. Tan, C. Fisher, and E. Wiltshaw

The endodermal sinus tumour and clear cell ovarian cancer
Ann Oncol 5: 753-756.
[Abstract] [PDF] [Request Permissions]

Short report:

M. A. Dimopoulos, S. Arbuck, M. Huber, D. Weber, R. Luckett, K. Delasalle, and R. Alexanian

Primary therapy of multiple myeloma with paclitaxel (Taxol)
Ann Oncol 5: 757-759.
[Abstract] [PDF] [Request Permissions]

A. Falcone, E. Pfanner, S. Ricci, M. Bertuccelli, C. Cianci, M. Carrai, S. De Marco, A. Ceribelli, M. Barduagni, F. Calabresi, G. Cornelia, R. Sarcina, V. Lorusso, C. Gallo Stampino, A. Pandolfi, P. Bruzzi, and P. F. Conte

Oral doxifluridine in elderly patients with metastatic colorectal cancer: A multicenter phase II study
Ann Oncol 5: 760-762.
[Abstract] [PDF] [Request Permissions]

F. Orlandi, P. Caraci, A. Berruti, B. Puligheddu, G. Pivano, L. Dogliotti, and A. Angeli

Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer
Ann Oncol 5: 763-765.
[Abstract] [PDF] [Request Permissions]

M. Knowling, V. Bramwell, E. Eisenhauer, G. Boos, A. Bodurtha, and I. Quirt

Phase II trial of 10-EDAM in advanced soft tissue sarcoma: A Study of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 5: 766-768.
[Abstract] [PDF] [Request Permissions]

R. Rodriguez, M. Machiavelli, B. Leone, A. Romero, M. A. Cuevas, M. Langhi, L. Romero Acuna, J. Romero Acuna, S. Amato, M. Barbieri, C. Vallejo, M. Rabinovich, J. Perez, C. Sabatini, E. Ortiz, M. Salvadori, and J. Lacava

Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
Ann Oncol 5: 769-770.
[Abstract] [PDF] [Request Permissions]

Letters:

H. Bonnefoi, G. B. Zulian, R. O. Mirimanoff, B. Mermillod, and P. Alberto

Priming low-dose chest radiotherapy followed by chemotherapy for limited small-cell lung cancer
Ann Oncol 5: 771-772.
[PDF] [Request Permissions]

D. R. A. Mans, A. Scaletzky, D. Becker, J. Rodrigues de Oliveira, C. M. Pinheiro, C. Bittar, A. F. Ferreira Filho, V. L. Machado, J. L. Ritt, F. A. Jung, A. Leyva, and G. Schwartsmann

Two new cases of hyperpyrimidinuria associated with excessive 5-fluorouracil toxicity
Ann Oncol 5: 772-773.
[PDF] [Request Permissions]

S. Tanneberger, A. Panetta, and F. Pannuti

How does the message of cancer specialists affect routine medical practice? Only sixty percent of surgical adjuvant breast cancer treatment is based on hormone receptor status
Ann Oncol 5: 773-774.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements:

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 5: 775.
[PDF] [Request Permissions]

ESMO APPLICATION FOR MEMBERSHIP:

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Ann Oncol 5: 776.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.